Stock earnings page

Kalaris Therapeutics, Inc. (KLRS)

Track the next or latest earnings date for Kalaris Therapeutics, Inc. , review consensus estimates, and see cached AI analysis for recent quarterly results.

View this earnings week Open in the app

Recent earnings news

Buy Allovir Inc Stock – KLRS Stock Quote Today & Investment Insights - Public.com
public.com · Recent

Looking to buy Allovir Inc Stock? Get the latest KLRS quote, news, earnings, forecast, price targets, and market insights. Start investing on Public.com.

Kalaris Appoints Laurie Keating to Board of Directors | INN
investingnews.com · 14 hours ago

Kalaris Therapeutics, Inc. (Nasdaq: KLRS) ("Kalaris"), a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases, today announced the appointment of Laurie Keating to its Board of Directors, effective August 1, 2026.

Kalaris Therapeutics (KLRS) – Analysts’ Weekly Ratings Changes - Markets Daily
www.themarketsdaily.com · 1 week ago

Several analysts have recently updated their ratings and price targets for Kalaris Therapeutics (NASDAQ: KLRS): 6/23/2026 – Kalaris Therapeutics was downgraded by Weiss Ratings from “sell (d-)” to “sell (e+)”. 6/15/2026 – Kalaris Therapeutics is now covered by TD Cowen.

Allovir Inc (KLRS) Earnings: Latest Report, Earnings Call & Financials
public.com · Recent

Following the last earnings report on Nov 12, 2025, Allovir Inc (KLRS)'s stock price moved — from — to —.

KLRS: Kalaris Therapeutics Latest Stock Price, Analysis, News and Trading Ideas
stocktwits.com · Recent

Get real-time Kalaris Therapeutics (KLRS) stock price, news, financials, community insights, and trading ideas. Join 10 million+ investors and traders tracking markets in real-time on Stocktwits.

Latest earnings date

Mar 17, 2026

Time not specified

Fiscal quarter: 2025-12-31

EPS estimate: -$0.56

Revenue estimate: N/A

Market cap: $159.34M

Analysis snapshot

No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.

Recent earnings history

Browse the calendar week

Date	Quarter	Report window	EPS est.	Revenue est.
Mar 17, 2026	2025-12-31	Time not specified	-$0.56	N/A